Emerging Biosimilars in Therapeutics

The main theme of this track is to have sound knowledge in the emerging biosimilar products like Recombinant blood products, therapeutic proteins, vaccines, Growth hormones, Biosimilar peptides, therapeutic proteins, biosimilar antibodies.Biosimilar insulins are the most expected ones in the class to enter the biosimilar landscape as patents for major branded insulin products start to expire in the next few years

The proportion of different biosimilars that reached market are Low Molecular Weight Heparins 44%, Epoetins 19%, HGH 11%, G-CSFs 7%, Interferons 6%, Insulins 5%, Others 8%.

  • Recombinant blood products
  • Biosimilars interferon
  • Biosimilar monoclonal antibodies
  • Biosimilars in cancer treatment
  • Recombinant therapeutic proteins
  • Biosimilar peptides
  • Insulin Biosimilars
  • Growth hormones
  • Recombinant vaccines
  • Biosimilars in rheumatic diseases
  • Recombinant therapeutic proteins
  • Biologics in autoimmune disease

Related Conference of Emerging Biosimilars in Therapeutics

June 06-07, 2018

International Conference on Pharmaceutical Research and Development

Philadelphia, Pennsylvania, USA
June 08-09, 2018

8th International Conference and Exhibition on GMP, GCP & Quality Control

Philadelphia, Pennsylvania, USA
June 08-09, 2018

7th International conference on Pharmaceutical Auditing

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4th International Conference on Drug Discovery, Designing and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan

3rd International Conference on Generics Drugs and Biosimilars

November 15-17, 2018 | Frankfurt, Germany
October 18-19, 2018

18th World Pharma Congress

Warsaw, Poland
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Emerging Biosimilars in Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in